LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.

    Silva Arouche, Tiago da / Reis, Arthur Ferreira / Martins, Anderson Yuri / S Costa, Jose Francisco / Carvalho Junior, Raul Nunes / J C Neto, Antonio Maia

    Journal of nanoscience and nanotechnology

    2020  Volume 20, Issue 12, Page(s) 7311–7323

    Abstract: We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and ... ...

    Abstract We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and chloroquine interacting with the main COVID-19 protease in complex with a COVID-19 N3 protease inhibitor. The highest values of affinity energy found in order from highest to lowest were chloroquine (CHL), hydroxychloroquine (HYC), favipiravir (FAV), galidesivir (GAL), remdesivir (REM) and ribavirin (RIB). The possible formation of hydrogen bonds, associations through London forces and permanent electric dipole were analyzed. The values of affinity energy obtained for the hydroxychloroquine ligands was -9.9 kcal/mol and for the chloroquine of -10.8 kcal/mol which indicate that the coupling contributes to an effective improvement of the affinity energies with the protease. Indicating that, the position chosen to make the substitutions may be a pharmacophoric group, and cause changes in the protease.
    MeSH term(s) Adenine/administration & dosage ; Adenine/analogs & derivatives ; Adenine/chemistry ; Adenine/pharmacology ; Adenosine Monophosphate/administration & dosage ; Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/chemistry ; Adenosine Monophosphate/pharmacology ; Alanine/administration & dosage ; Alanine/analogs & derivatives ; Alanine/chemistry ; Alanine/pharmacology ; Amides/administration & dosage ; Amides/chemistry ; Amides/pharmacology ; Antiviral Agents/administration & dosage ; Antiviral Agents/chemistry ; Antiviral Agents/pharmacology ; Betacoronavirus/drug effects ; Betacoronavirus/enzymology ; Binding Sites ; Chloroquine/administration & dosage ; Chloroquine/chemistry ; Chloroquine/pharmacology ; Coronavirus Infections/drug therapy ; Coronavirus Infections/virology ; Cysteine Endopeptidases/chemistry ; Drug Interactions ; Humans ; Hydrogen Bonding ; Hydroxychloroquine/administration & dosage ; Hydroxychloroquine/chemistry ; Hydroxychloroquine/pharmacology ; Ligands ; Molecular Docking Simulation ; Nanotechnology ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/virology ; Protease Inhibitors/administration & dosage ; Protease Inhibitors/chemistry ; Protease Inhibitors/pharmacology ; Pyrazines/administration & dosage ; Pyrazines/chemistry ; Pyrazines/pharmacology ; Pyrrolidines/administration & dosage ; Pyrrolidines/chemistry ; Pyrrolidines/pharmacology ; Ribavirin/administration & dosage ; Ribavirin/chemistry ; Ribavirin/pharmacology ; Static Electricity ; Viral Nonstructural Proteins/antagonists & inhibitors ; Viral Nonstructural Proteins/chemistry
    Chemical Substances Amides ; Antiviral Agents ; Ligands ; Protease Inhibitors ; Pyrazines ; Pyrrolidines ; Viral Nonstructural Proteins ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; Ribavirin (49717AWG6K) ; Hydroxychloroquine (4QWG6N8QKH) ; Chloroquine (886U3H6UFF) ; 3C-like proteinase, Coronavirus (EC 3.4.22.-) ; Cysteine Endopeptidases (EC 3.4.22.-) ; favipiravir (EW5GL2X7E0) ; Adenine (JAC85A2161) ; Alanine (OF5P57N2ZX) ; immucillin A (OLF97F86A7)
    Keywords covid19
    Language English
    Publishing date 2020-07-23
    Publishing country United States
    Document type Journal Article
    ISSN 1533-4899
    ISSN (online) 1533-4899
    DOI 10.1166/jnn.2020.18955
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking

    Silva Arouche, Tiago da / Reis, Arthur Ferreira / Martins, Anderson Yuri / S Costa, Jose Francisco / Carvalho Junior, Raul Nunes / J C Neto, Antonio Maia

    J Nanosci Nanotechnol

    Abstract: We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and ... ...

    Abstract We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and chloroquine interacting with the main COVID-19 protease in complex with a COVID-19 N3 protease inhibitor. The highest values of affinity energy found in order from highest to lowest were chloroquine (CHL), hydroxychloroquine (HYC), favipiravir (FAV), galidesivir (GAL), remdesivir (REM) and ribavirin (RIB). The possible formation of hydrogen bonds, associations through London forces and permanent electric dipole were analyzed. The values of affinity energy obtained for the hydroxychloroquine ligands was -9.9 kcal/mol and for the chloroquine of -10.8 kcal/mol which indicate that the coupling contributes to an effective improvement of the affinity energies with the protease. Indicating that, the position chosen to make the substitutions may be a pharmacophoric group, and cause changes in the protease.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #680345
    Database COVID19

    Kategorien

  3. Article ; Online: Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking

    Silva Arouche, Tiago da / Reis, Arthur Ferreira / Martins, Anderson Yuri / S. Costa, Jose Francisco / Carvalho Junior, Raul Nunes / J. C. Neto, Antonio Maia

    Journal of Nanoscience and Nanotechnology

    2020  Volume 20, Issue 12, Page(s) 7311–7323

    Abstract: We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and ... ...

    Abstract We started a study on the molecular docking of six potential pharmacologically active inhibitors compounds that can be used clinically against the COVID-19 virus, in this case, remdesivir, ribavirin, favipiravir, galidesivir, hydroxychloroquine and chloroquine interacting with the main COVID-19 protease in complex with a COVID-19 N3 protease inhibitor. The highest values of affinity energy found in order from highest to lowest were chloroquine (CHL), hydroxychloroquine (HYC), favipiravir (FAV), galidesivir (GAL), remdesivir (REM) and ribavirin (RIB). The possible formation of hydrogen bonds, associations through London forces and permanent electric dipole were analyzed. The values of affinity energy obtained for the hydroxychloroquine ligands was −9.9 kcal/mol and for the chloroquine of −10.8 kcal/mol which indicate that the coupling contributes to an effective improvement of the affinity energies with the protease. Indicating that, the position chosen to make the substitutions may be a pharmacophoric group, and cause changes in the protease.
    Keywords General Materials Science ; Bioengineering ; General Chemistry ; Condensed Matter Physics ; Biomedical Engineering ; covid19
    Language English
    Publisher American Scientific Publishers
    Publishing country us
    Document type Article ; Online
    ISSN 1533-4880
    DOI 10.1166/jnn.2020.18955
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top